|
English
|
正體中文
|
简体中文
|
2826208
|
|
???header.visitor??? :
31898077
???header.onlineuser??? :
1471
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"buchwald u k"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2022 |
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)
|
Platt, H.L.;Cardona, J.F.;Haranaka, M.;Schwartz, H.I.;Narejos, Perez S.;Dowell, A.;Chang, Chang C.-J.;Dagan, R.;Tamms, G.M.;Sterling, T.;Morgan, L.;Shi, Y.;Pedley, A.;Musey, L.K.;Buchwald, U.K. |
| 國立成功大學 |
2021 |
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)
|
Song, J.-Y.;Chang, Chang C.-J.;Andrews, C.;Diez-Domingo, J.;Oh, M.-D.;Dagan, R.;Hartzel, J.;Pedley, A.;Li, J.;Sterling, T.;Tamms, G.;Chiarappa, J.A.;Lutkiewicz, J.;Musey, L.;Tu, Y.;Buchwald, U.K. |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
